The primary hyperoxalurias

Bernd Hoppe, Bodo B. Beck, Dawn S. Milliner

Research output: Contribution to journalArticle

206 Citations (Scopus)

Abstract

The primary hyperoxalurias (PHs) are rare disorders of glyoxylate metabolism in which specific hepatic enzyme deficiencies result in overproduction of oxalate. Due to the resulting severe hyperoxaluria, recurrent urolithiasis or progressive nephrocalcinosis are principal manifestations. End stage renal failure frequently occurs and is followed by systemic oxalate deposition along with its devastating effects. Due to the lack of familiarity with PHs and their heterogeneous clinical expressions, the diagnosis is often delayed until there is advanced disease. In recent years, improvements in medical management have been associated with better patient outcomes. Although there are several therapeutic options that can help prevent early kidney failure, the only curative treatment to date is combined liver-kidney transplantation in patients with type I PH. Promising areas of investigation are being identified. Knowledge of the spectrum of disease expression, early diagnosis, and initiation of treatment before renal failure are essential to realize a benefit for patients.

Original languageEnglish (US)
Pages (from-to)1264-1271
Number of pages8
JournalKidney International
Volume75
Issue number12
DOIs
StatePublished - Jun 2009

Fingerprint

Primary Hyperoxaluria
Oxalates
Renal Insufficiency
Hyperoxaluria
Nephrocalcinosis
Urolithiasis
Liver Transplantation
Kidney Transplantation
Chronic Kidney Failure
Early Diagnosis
Therapeutics
Liver
Enzymes

Keywords

  • Nephrocalcinosis
  • Oxalate
  • Systemic oxalosis
  • Urolithiasis

ASJC Scopus subject areas

  • Nephrology

Cite this

Hoppe, B., Beck, B. B., & Milliner, D. S. (2009). The primary hyperoxalurias. Kidney International, 75(12), 1264-1271. https://doi.org/10.1038/ki.2009.32

The primary hyperoxalurias. / Hoppe, Bernd; Beck, Bodo B.; Milliner, Dawn S.

In: Kidney International, Vol. 75, No. 12, 06.2009, p. 1264-1271.

Research output: Contribution to journalArticle

Hoppe, B, Beck, BB & Milliner, DS 2009, 'The primary hyperoxalurias', Kidney International, vol. 75, no. 12, pp. 1264-1271. https://doi.org/10.1038/ki.2009.32
Hoppe B, Beck BB, Milliner DS. The primary hyperoxalurias. Kidney International. 2009 Jun;75(12):1264-1271. https://doi.org/10.1038/ki.2009.32
Hoppe, Bernd ; Beck, Bodo B. ; Milliner, Dawn S. / The primary hyperoxalurias. In: Kidney International. 2009 ; Vol. 75, No. 12. pp. 1264-1271.
@article{a00860005c594bceac4abcd85931dcff,
title = "The primary hyperoxalurias",
abstract = "The primary hyperoxalurias (PHs) are rare disorders of glyoxylate metabolism in which specific hepatic enzyme deficiencies result in overproduction of oxalate. Due to the resulting severe hyperoxaluria, recurrent urolithiasis or progressive nephrocalcinosis are principal manifestations. End stage renal failure frequently occurs and is followed by systemic oxalate deposition along with its devastating effects. Due to the lack of familiarity with PHs and their heterogeneous clinical expressions, the diagnosis is often delayed until there is advanced disease. In recent years, improvements in medical management have been associated with better patient outcomes. Although there are several therapeutic options that can help prevent early kidney failure, the only curative treatment to date is combined liver-kidney transplantation in patients with type I PH. Promising areas of investigation are being identified. Knowledge of the spectrum of disease expression, early diagnosis, and initiation of treatment before renal failure are essential to realize a benefit for patients.",
keywords = "Nephrocalcinosis, Oxalate, Systemic oxalosis, Urolithiasis",
author = "Bernd Hoppe and Beck, {Bodo B.} and Milliner, {Dawn S.}",
year = "2009",
month = "6",
doi = "10.1038/ki.2009.32",
language = "English (US)",
volume = "75",
pages = "1264--1271",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - The primary hyperoxalurias

AU - Hoppe, Bernd

AU - Beck, Bodo B.

AU - Milliner, Dawn S.

PY - 2009/6

Y1 - 2009/6

N2 - The primary hyperoxalurias (PHs) are rare disorders of glyoxylate metabolism in which specific hepatic enzyme deficiencies result in overproduction of oxalate. Due to the resulting severe hyperoxaluria, recurrent urolithiasis or progressive nephrocalcinosis are principal manifestations. End stage renal failure frequently occurs and is followed by systemic oxalate deposition along with its devastating effects. Due to the lack of familiarity with PHs and their heterogeneous clinical expressions, the diagnosis is often delayed until there is advanced disease. In recent years, improvements in medical management have been associated with better patient outcomes. Although there are several therapeutic options that can help prevent early kidney failure, the only curative treatment to date is combined liver-kidney transplantation in patients with type I PH. Promising areas of investigation are being identified. Knowledge of the spectrum of disease expression, early diagnosis, and initiation of treatment before renal failure are essential to realize a benefit for patients.

AB - The primary hyperoxalurias (PHs) are rare disorders of glyoxylate metabolism in which specific hepatic enzyme deficiencies result in overproduction of oxalate. Due to the resulting severe hyperoxaluria, recurrent urolithiasis or progressive nephrocalcinosis are principal manifestations. End stage renal failure frequently occurs and is followed by systemic oxalate deposition along with its devastating effects. Due to the lack of familiarity with PHs and their heterogeneous clinical expressions, the diagnosis is often delayed until there is advanced disease. In recent years, improvements in medical management have been associated with better patient outcomes. Although there are several therapeutic options that can help prevent early kidney failure, the only curative treatment to date is combined liver-kidney transplantation in patients with type I PH. Promising areas of investigation are being identified. Knowledge of the spectrum of disease expression, early diagnosis, and initiation of treatment before renal failure are essential to realize a benefit for patients.

KW - Nephrocalcinosis

KW - Oxalate

KW - Systemic oxalosis

KW - Urolithiasis

UR - http://www.scopus.com/inward/record.url?scp=67349122278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349122278&partnerID=8YFLogxK

U2 - 10.1038/ki.2009.32

DO - 10.1038/ki.2009.32

M3 - Article

VL - 75

SP - 1264

EP - 1271

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 12

ER -